Noffar Bar
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE) (NCT06993675) | Noffar Bar | 2025-08-21 |
Track Noffar Bar automatically
Every clearance here is in the API, with alerts when new ones post.